Evonile Pharma Approves INR 8.85 Billion Rights Issue Terms
Novartis India Ltd 路 Rights Issue 路 05 Nov 2026, 1:16 am
Evonile Pharma Approves INR 8.85 Billion Rights Issue Terms Evonile Pharma Limited has fixed 11th Nov'26 as the record date for its INR 8,847.54 million rights issue of 10,287,832 partly paid-up equity shares priced at INR 860 per share (5:12 ratio). Payment is structured with INR 645 on application and INR 215 on the first and final call. The issue opens on 19th Nov'26 and closes on 3rd Dec'26, with renunciation ending 27th Nov'26. Total outstanding shares will expand from 24,690,797 to 34,978,629 post-issue, with tentative listing scheduled for 9th Dec'26.
Original exchange filing (PDF)
More announcements from Novartis India Ltd
- Transcript of the Earnings Call held on Wednesday, November 04, 2026. 路 06 Nov 2026
- Submission of the Letter of Offer in connection with the proposed Rights Issue of the Partly Paid-up Equity Shares of the Company. 路 06 Nov 2026
- Outcome of the Board Meeting held today i.e. November 04, 2026 路 05 Nov 2026
- Outcome of the meeting of the Rights Issue Committee held today i.e. November 04, 2026 路 05 Nov 2026
- Intimation of the Audio Recording of the Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2026, held today i.e. on Wednesday, November 04, 2026. 路 04 Nov 2026
- Intimation of the Integrated Unaudited Financial Results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
- Press Release - Unaudited Financial Results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
- Submission of Investor Presentation for the Earnings Call scheduled on Wednesday, November 04, 2026. 路 04 Nov 2026
